IDAC 38th Annual Southern California Symposium July 13 - 14, 2024
Huntington Beach Hyatt Regency
Saturday, July 13
(Topics and Times Subject to Change)
0730 – 0830: Check-in, Breakfast Buffett - Industry exhibit visits
0830-0840 – Opening Remarks – Dr. Suman Radhakrishna, President, IDAC
0840 – 0940 - The Updated Duke Criteria: Work-up for Infective Endocarditis – James McKinnell, MD, Infectious Disease Specialist, Milefchik-Rand Medical Group, Torrance Memorial Medical Center- In Memory of Arnold Bayer, MD
0940 – 1000 - Morning Break, Vendor Visits
1000 – 1100 - Complicated Infected Pacemaker Leads and Current Management Practices - RayShaerf, MD. Adjunct Clinical Associate Professor, Cedars-Sinai, Cardiac Surgery
1100-1200 - Surgical Indications for Infective Endocarditis and How to Prevent Post-operative Infections – Loren Miller, MD, MPH, Investigator -The Lundquist Institute, Associate Chief - Division of Infectious Diseases, Department of Medicine - Harbor-UCLA Medical Center, Professor of Medicine - David Geffen School of Medicine at UCLA
1200 – 1315 - Lunch, Vendor Visits,
12:30 - Breakout Sessions - Members Meeting
1315 – 1415 – Antibiotic Selection for Infective Endocarditis - Review of the Basics – Jim Lewis, Pharm D, FIDSA, Clinical Supervisor for Infectious Disease, Oregon Health and Science University
1415 – 1430 - Afternoon Break, Industry exhibit visits
1430 – 1530 – Antibiotic Selection for Infective Endocarditis - How to Manage the Impossible, Deep Salvage for MRSA, MSSA, VRE, Gram Negatives, Fungi - George Sakoulas, MD, Adjunct Professor of Pediatrics at the University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics
1530 – 1630 - Outcomes - Oral Antibiotic Treatment for Endocarditis (Poet and New Lancet Study on Oral Antimicrobials for MRSA) – Jim Lewis, Pharm D, FIDSA, Clinical Supervisor for Infectious Disease, Oregon Health and Science University
Sunday, July 14
0730 – 0830 - Breakfast Buffett, Industry exhibit visits
0830-0840 – Welcome - Dr. Suman Radhakrishna, IDAC President
0840 – 0940 - Dalbavancin for Complicated Staph Bacteremia & Right Sided Endocarditis: Results from the DOTS Trial – Nicholas Turner, MD, MHSc, Assistant Professor of Medicine, Infectious Diseases, Duke University
1000 – 1100 – Expanding Hospital Bloodstream Infection Surveillance: Infection Prevention Strategies in PIV Surveillance and Hospital-Onset Bacteremia and Fungemia- Jessica Alicdan, MPH, CIC. Infection Preventionist, UC San Diego Health, Department of Infection Prevention and Clinical Epidemiology (IPCE)
1100-1200 - The Power of Plasma Microbial Cell-Free DNA: Real World Application of A Liquid Biopsy for Infective Endocarditis -Uriel S. Sandkovsky, M.D., M.S. Infectious Diseases Attending Physician, Baylor University Medical Center at Dallas, Transplant and Clinical Infectious Diseases Attending, North Texas Infectious Disease Consultants
1200 – Symposium Ends